Leucine Rich Bio Achieves Prestigious NABL Accreditation - A First in Microbiome space in India

Leucine Rich Bio, South Asia’s pioneering microbiome company, is proud to announce that it has achieved  NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation. Previously it had received the NABH (National Accreditation Board for Hospitals & Healthcare Providers) accreditations. It is the only microbiome-focused company in India to hold these alongside its existing ISO 9001:2015 (Quality Management Systems) and ISO 17025 (Testing & Calibration Laboratories) certifications.

●      NABL accreditation affirms technical competence and reliability of Leucine Rich Bio’s testing processes under the ISO/IEC 17025 standards.

●      NABH accreditation ensures excellence in clinical quality and patient safety.

●      Maintaining ISO 9001:2015 reflects the company’s commitment to global quality standards, while ISO 17025 ensures the validity of its lab results.

Combining these achievements establishes Leucine Rich Bio as the only microbiome company in India with a comprehensive suite of certifications, solidifying its leadership in integrating cutting-edge science, clinical rigor, and preventive healthcare.

These certifications demonstrate that every stage, from sample collection to AI-driven analysis and reporting, is subject to stringent quality controls. This translates to higher accuracy, better clinical trust, and safer patient outcomes, essential in the complex field of microbiome diagnostics.

Also Read: Geriatric Medicine Boom: Asia's Stunning Growth and Opportunities

“Our NABL & NABH accreditations mark a significant leap forward in validating microbiome science as reliable and clinically meaningful. These recognitions reinforce our aim to transform preventive healthcare through data-driven insights,” said  Prabhath Manjappa, Co‑founder & CPO, Leucine Rich Bio.

Dr Debojyoti Dhar, Co-founder and Director also echoed the same sentiment, stating, “Getting NABL and NABH accreditations is a significant milestone in our journey to become a reliable and trustworthy company when it comes to microbiome testing solutions.”

Kumar Sankaran, CEO of Leucine Rich Bio, added, “This is a milestone for microbiome-driven medicine in India. By combining international and national accreditations, we are setting new benchmarks for quality, safety, and diagnostic precision.”